17.36% Less Aemetis Inc (NASDAQ:AMTX) Shares Shorted

Aemetis, Inc. (NASDAQ:AMTX) Corporate Logo

Aemetis Inc (NASDAQ:AMTX) had a decrease of its shares shorted by 17.36%. FINRA published shares shorted of AMTX’s total 91,400 shares. The down change of 17.36% from 110,600 shares was reported. 1 days will cost AMTX with 106,800 average volume to restore its former position. Aemetis Inc float short is 0.62%.

Ticker’s shares touched $0.95 during the last trading session after 1.04% change.Aemetis, Inc. has volume of 696 shares. Since March 6, 2018 AMTX has risen 75.00% and is uptrending. AMTX outperformed by 70.63% the S&P 500.

Aemetis, Inc. operates as an international renewable fuels and bio-chemicals firm in North America and India.The company has $19.33 million market cap. It focuses on the production of advanced fuels and chemicals through the acquisition, development, and commercialization of technologies that replace traditional petroleum products by conversion of first-generation ethanol and biodiesel plants into advanced bio refineries.Last it reported negative earnings. The firm owns and operates a biodiesel plant in Kakinada, India; and an ethanol plant in Keyes, California.

For more Aemetis, Inc. (NASDAQ:AMTX) news published recently go to: Nasdaq.com, Nasdaq.com, Globenewswire.com, Globenewswire.com or Seekingalpha.com. The titles are as follows: “Aemetis Plant Expands Customer Base with Sales of Biodiesel to Retail Fuel Stations in India – Nasdaq” published on February 15, 2019, “Energy Sector Update for 02/04/2019: AMTX,ALTM,CNX – Nasdaq” on February 04, 2019, “Aemetis Advanced Biorefinery Named #1 Waste-to-Value Project in the World – GlobeNewswire” with a publish date: June 19, 2018, “Aemetis $5 Million Grant Announced For Low Carbon Fuels Riverbank Biorefinery – GlobeNewswire” and the last “ZYNE, MXWL among premarket gainers – Seeking Alpha” with publication date: February 04, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.